PFO
ABMD

Pathstone Family Office’s Abiomed Inc ABMD Stock Holding History

Pathstone Family Office’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,901
Closed -$959K – 1624
2022
Q3 		$959K Buy
+3,901
New +$1.05M 0.01% 763
2021
Q1 		– Sell
-52
Closed -$17K – 1434
2020
Q4 		$17K Buy
+52
New +$14.4K ﹤0.01% 752
2019
Q2 		– Sell
-193
Closed -$54K – 950
2019
Q1 		$54K Buy
193
+5
+3% +$1.66K 0.01% 294
2018
Q4 		$61K Buy
+188
New +$65.3K 0.02% 168

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pathstone Family Office's ABMD Position: Q4 2022 in Review

Pathstone Family Office sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,901 shares — an estimated $959K sold.

Pathstone Family Office first reported a position in ABMD in Q4 2018 and held it in 4 quarters. The position peaked at $959K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Pathstone Family Office reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Pathstone Family Office sold 3,901 Abiomed Inc shares in Q4 2022, an estimated $959K.
  • Pathstone Family Office first reported a position in Abiomed Inc in Q4 2018 and held it in 4 quarters.
  • Pathstone Family Office's Abiomed Inc position peaked at $959K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Pathstone Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.